Evidence map›Paper›PMID 34125272›Full record

ArticleCurrent microbiology2021

Evaluation of the Effectiveness of Soil Streptomyces Isolates for Induction of Plant Resistance Against Tomato mosaic virus (ToMV).

Mohamed Taha, Mohamed Ghaly, Hala Atwa, Momen Askoura

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Consortia of3 Biotech · 2024
    Article
  4. Article
  5. Streptomyces can be an excellent plant growth manager.World journal of microbiology & biotechnology · 2022
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mohamed TahaDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
Mohamed GhalyDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
Hala AtwaDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.
Momen AskouraDepartment of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt. momenaskora@yahoo.com.ORCID http://orcid.org/0000-0002-4282-6789
Zagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability of various Streptomyces isolates obtained from soil to induce systemic resistance in tomato (Solanum lycopersicum cv. Supra) plant against Tomato mosaic virus (ToMV) was characterized in current study. Importantly, of nine Streptomyces isolates tested herein, the culture filtrate (CF) of one isolate, designated as Streptomyces ovatisporus LC597360, was the most effective. It exhibited 93.9% biocontrol efficacy and induced a significant decrease (17.6 ± 0.8%) of symptoms severity compared with infected control plants. These finding were confirmed using I-ELISA showing that ToMV concentration was significantly reduced in plants treated with S. ovatisporus LC597360 CF as compared with plants inoculated with ToMV. Moreover, treatment with CF of S. ovatisporus LC597360 not only increased activity of defense-related enzymes such as ascorbate oxidase, catalase, peroxidase, and polyphenol oxidase, but also induced plant growth promotion. The present study is the first one that demonstrates the potential of S. ovatisporus LC597360 in biocontrol of ToMV and investigated its antiviral mechanisms.

Indexed as

Solanum lycopersicumStreptomycesPlant DiseasesSoilTobamovirusSoil

Identifiers

PMID34125272
OpenAlexW3168178922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.